# US 2025/0154587 A1 · Digital counting of individual molecules by stochastic attachment of diverse labels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154587 A1
- Document ID: US20250154587A1
- Status: Published application
- Kind: A1
- Application number: 19/022,242
- Filed: 2025-01-15
- Published: 2025-05-15
- Earliest claimed: 2009-12-15
- Assignees: Becton, Dickinson and Company
- Applicants: Becton, Dickinson and Company
- Inventors: Stephen P.A. Fodor; Glenn K. Fu
- Web page: https://patentgrep.com/patent/US20250154587A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/6851: Quantitative amplification
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B 25/20: Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Compositions, methods and kits are disclosed for high-sensitivity single molecule digital counting by the stochastic labeling of a collection of identical molecules by attachment of a diverse set of labels. Each copy of a molecule randomly chooses from a non-depleting reservoir of diverse labels. Detection may be by a variety of methods including hybridization based or sequencing. Molecules that would otherwise be identical in information content can be labeled to create a separately detectable product that is unique or approximately unique in a collection. This stochastic transformation relaxes the problem of counting molecules from one of locating and identifying identical molecules to a series of binary digital questions detecting whether preprogrammed labels are present. The methods may be used, for example, to estimate the number of separate molecules of a given type or types within a sample.

## Claims

### Claim 1

A composition, comprising:
a set of diverse labels,
wherein the set of diverse labels comprises labels with m different label sequences,
wherein a label comprises a cohesive DNA end;
two or more enzymes capable of modifying both ends of fragmented DNA to generate ends that are compatible for ligation with said cohesive end,
wherein the fragmented DNA comprises four or more distinct target molecules comprising SNP(s),
wherein the two or more enzymes comprise one or more polymerases comprising 3′ to 5′ exonuclease activity and/or 5′ to 3′ polymerase activity,
wherein the two or more enzymes comprise one or more phosphate transfer enzymes, wherein a phosphate transfer enzyme is capable of transferring a phosphate group from ATP to a 5′-OH terminus of a nucleic acid;
four or more biotin-tagged oligonucleotides containing sequences each complementary to at least one of the four or more distinct target molecules,
wherein at least one of the four or more distinct target nucleic acid molecules is PIK3R1, MYC, CCND2, or CDKN2A;
streptavidin magnetic beads; and
one or more ligases.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the one or more polymerases comprise one or more of Klenow fragment, T4 DNA polymerase, Bst polymerase, Pfu polymerase, Pow polymerase, Vent polymerase, Pab polymerase, Terminal deoxynucleotidyl transferase (TdT), Pol I, Pol II, and Pol III.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the fragmented DNA comprises sheared genomic DNA.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the one or more phosphate transfer enzymes comprise T4 Polynucleotide Kinase.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the label comprises a universal primer.

### Claim 6 (depends on 1)

The composition of claim 1, wherein m is between 100 and 1,000.

### Claim 7 (depends on 1)

The composition of claim 1, wherein m is between 1,000 and 10,000.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the label sequence is at least 6 nucleotides in length.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the label sequence is 6-15 nucleotides in length.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the composition comprises fragmented DNA, and wherein the fragmented DNA comprises a plurality of first target molecules and a plurality of second target molecules.

### Claim 11 (depends on 10)

The composition of claim 10, wherein n1 and n2 are numbers of occurrences of the first target molecule and the second target molecule, respectively, and wherein the ratio of the greater of n1 and n2 to m is smaller than 0.2.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the composition comprises a reverse transcriptase.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the two or more enzymes comprise T4 DNA polymerase and T4 Polynucleotide Kinase.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the two or more enzymes comprise T4 DNA polymerase, Klenow fragment, and T4 Polynucleotide Kinase.

### Claim 15 (depends on 1)

The composition of claim 1, wherein the fragmented DNA is derived from a sample.

### Claim 16 (depends on 15)

The composition of claim 15, wherein the sample is a tissue.

### Claim 17 (depends on 15)

The composition of claim 15, wherein the sample is from a human.

### Claim 18 (depends on 1)

The composition of claim 1, wherein the one or more ligases comprise T4 DNA ligase.

### Claim 19 (depends on 1)

The composition of claim 1, wherein the one or more polymerases comprise T4 DNA polymerase.

### Claim 20 (depends on 1)

The composition of claim 1, wherein the one or more polymerases comprise Klenow fragment and T4 DNA polymerase.
